Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #28,601 to #28,650.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Emergent stress testing in young people (2 revisions)
  2. Emerin (2 revisions)
  3. Emil Kraepelin (2 revisions)
  4. Emissary veins (2 revisions)
  5. Emissivity (2 revisions)
  6. Emollient (2 revisions)
  7. Emopamil binding protein (2 revisions)
  8. Emotion (2 revisions)
  9. Emotional dysregulation (2 revisions)
  10. Emotional exhaustion (2 revisions)
  11. Emotionally unstable personality disorder (2 revisions)
  12. Emotions in Decision Making (2 revisions)
  13. Emphysema echocardiography or ultrasound (2 revisions)
  14. Emphysema epidemiology and demographics (2 revisions)
  15. Emphysema natural history (2 revisions)
  16. Emphysema other diagnostic studies (2 revisions)
  17. Emphysema risk factors (2 revisions)
  18. Empirical treatment (2 revisions)
  19. Empty nose syndrome overview (2 revisions)
  20. Empyema case study one (2 revisions)
  21. Empyema cost-effectiveness of therapy (2 revisions)
  22. Empyema future or investigational therapies (2 revisions)
  23. Emtricitabine rilpivirine tenofovir adverse reactions (2 revisions)
  24. Emtricitabine rilpivirine tenofovir clinical pharmacology (2 revisions)
  25. Emtricitabine rilpivirine tenofovir drug interactions (2 revisions)
  26. Emtricitabine rilpivirine tenofovir indications and usage (2 revisions)
  27. Enalapril/Hydrochlorothiazide (2 revisions)
  28. Enalapril\Hydrochlorothiazide (2 revisions)
  29. Enamel pearl (2 revisions)
  30. Enamelin (2 revisions)
  31. Encainide detailed information (2 revisions)
  32. Encephalitis Epidemiology and Demographics (2 revisions)
  33. End-diastolic volume (2 revisions)
  34. End-stage disease (2 revisions)
  35. End-systolic volume (2 revisions)
  36. End cystolic volume (2 revisions)
  37. Endoamnioscopy (2 revisions)
  38. Endocannabinoid system (2 revisions)
  39. Endocardial cushion defect diagnostic study of choice (2 revisions)
  40. Endocardial cushion defect secondary prevention (2 revisions)
  41. Endocardial cushions (2 revisions)
  42. Endocardial fibroelastosis (2 revisions)
  43. Endocarditis CT (2 revisions)
  44. Endocarditis case study one (2 revisions)
  45. Endocardium (2 revisions)
  46. Endocrine disruptor (2 revisions)
  47. Endodermal sinus tumor case study one (2 revisions)
  48. Endodermal sinus tumor chest x ray (2 revisions)
  49. Endodermal sinus tumor echocardiography or ultrasound (2 revisions)
  50. Endodermal sinus tumor laboratory findings (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)